First Time Loading...

Vincent Medical Holdings Ltd
HKEX:1612

Watchlist Manager
Vincent Medical Holdings Ltd Logo
Vincent Medical Holdings Ltd
HKEX:1612
Watchlist
Price: 0.38 HKD Market Closed
Updated: Apr 25, 2024

Profitability Summary

49/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Vincent Medical Holdings Ltd

Revenue
718m HKD
Cost of Revenue
-477.6m HKD
Gross Profit
240.4m HKD
Operating Expenses
-173.3m HKD
Operating Income
67.1m HKD
Other Expenses
-9.8m HKD
Net Income
57.3m HKD

Margins Comparison
Vincent Medical Holdings Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
HK
Vincent Medical Holdings Ltd
HKEX:1612
248.3m HKD
33%
9%
8%
US
Abbott Laboratories
NYSE:ABT
185B USD
55%
16%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
130.9B USD
66%
25%
27%
US
Stryker Corp
NYSE:SYK
127.8B USD
64%
21%
15%
US
Boston Scientific Corp
NYSE:BSX
107.2B USD
70%
17%
11%
IE
Medtronic PLC
NYSE:MDT
105.3B USD
66%
20%
13%
US
Becton Dickinson and Co
NYSE:BDX
66.7B USD
41%
11%
6%
DE
Siemens Healthineers AG
XETRA:SHL
58.4B EUR
36%
10%
7%
US
Edwards Lifesciences Corp
NYSE:EW
52.7B USD
77%
29%
23%
US
Dexcom Inc
NASDAQ:DXCM
52.5B USD
64%
17%
15%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
344.8B CNY
65%
36%
33%
Country HK
Market Cap 248.3m HKD
Gross Margin
33%
Operating Margin
9%
Net Margin
8%
Country US
Market Cap 185B USD
Gross Margin
55%
Operating Margin
16%
Net Margin
14%
Country US
Market Cap 130.9B USD
Gross Margin
66%
Operating Margin
25%
Net Margin
27%
Country US
Market Cap 127.8B USD
Gross Margin
64%
Operating Margin
21%
Net Margin
15%
Country US
Market Cap 107.2B USD
Gross Margin
70%
Operating Margin
17%
Net Margin
11%
Country IE
Market Cap 105.3B USD
Gross Margin
66%
Operating Margin
20%
Net Margin
13%
Country US
Market Cap 66.7B USD
Gross Margin
41%
Operating Margin
11%
Net Margin
6%
Country DE
Market Cap 58.4B EUR
Gross Margin
36%
Operating Margin
10%
Net Margin
7%
Country US
Market Cap 52.7B USD
Gross Margin
77%
Operating Margin
29%
Net Margin
23%
Country US
Market Cap 52.5B USD
Gross Margin
64%
Operating Margin
17%
Net Margin
15%
Country CN
Market Cap 344.8B CNY
Gross Margin
65%
Operating Margin
36%
Net Margin
33%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Vincent Medical Holdings Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
HK
Vincent Medical Holdings Ltd
HKEX:1612
248.3m HKD
11%
8%
13%
11%
US
Abbott Laboratories
NYSE:ABT
185B USD
15%
8%
11%
9%
US
Intuitive Surgical Inc
NASDAQ:ISRG
130.9B USD
16%
14%
14%
20%
US
Stryker Corp
NYSE:SYK
127.8B USD
18%
8%
14%
11%
US
Boston Scientific Corp
NYSE:BSX
107.2B USD
9%
5%
8%
6%
IE
Medtronic PLC
NYSE:MDT
105.3B USD
8%
5%
8%
6%
US
Becton Dickinson and Co
NYSE:BDX
66.7B USD
5%
2%
5%
4%
DE
Siemens Healthineers AG
XETRA:SHL
58.4B EUR
8%
3%
7%
4%
US
Edwards Lifesciences Corp
NYSE:EW
52.7B USD
23%
16%
23%
23%
US
Dexcom Inc
NASDAQ:DXCM
52.5B USD
26%
9%
15%
16%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
344.8B CNY
34%
25%
34%
42%
Country HK
Market Cap 248.3m HKD
ROE
11%
ROA
8%
ROCE
13%
ROIC
11%
Country US
Market Cap 185B USD
ROE
15%
ROA
8%
ROCE
11%
ROIC
9%
Country US
Market Cap 130.9B USD
ROE
16%
ROA
14%
ROCE
14%
ROIC
20%
Country US
Market Cap 127.8B USD
ROE
18%
ROA
8%
ROCE
14%
ROIC
11%
Country US
Market Cap 107.2B USD
ROE
9%
ROA
5%
ROCE
8%
ROIC
6%
Country IE
Market Cap 105.3B USD
ROE
8%
ROA
5%
ROCE
8%
ROIC
6%
Country US
Market Cap 66.7B USD
ROE
5%
ROA
2%
ROCE
5%
ROIC
4%
Country DE
Market Cap 58.4B EUR
ROE
8%
ROA
3%
ROCE
7%
ROIC
4%
Country US
Market Cap 52.7B USD
ROE
23%
ROA
16%
ROCE
23%
ROIC
23%
Country US
Market Cap 52.5B USD
ROE
26%
ROA
9%
ROCE
15%
ROIC
16%
Country CN
Market Cap 344.8B CNY
ROE
34%
ROA
25%
ROCE
34%
ROIC
42%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More